Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.

Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y.

Oncotarget. 2018 Sep 25;9(75):34190. doi: 10.18632/oncotarget.26197. eCollection 2018 Sep 25.

2.

Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer.

Kato T, Hashimoto Y, Wong RK, Mitsui Y, Maekawa S, Chang I, Shahryari V, Yamamura S, Majid S, Saini S, Tabatabai ZL, Dahiya R, Deguchi T, Tanaka Y.

J Cell Mol Med. 2018 Oct;22(10):4676-4687. doi: 10.1111/jcmm.13696. Epub 2018 Aug 22.

3.

Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression.

Kulkarni P, Dasgupta P, Bhat NS, Shahryari V, Shiina M, Hashimoto Y, Majid S, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R.

Mol Cancer Res. 2018 Nov;16(11):1750-1760. doi: 10.1158/1541-7786.MCR-17-0762. Epub 2018 Jul 23.

PMID:
30037856
4.

Correction: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.

Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Dahiya R.

Br J Cancer. 2018 Aug;119(3):388. doi: 10.1038/s41416-018-0146-2.

PMID:
29930252
5.

MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.

Dasgupta P, Kulkarni P, Majid S, Shahryari V, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R.

Mol Cancer Ther. 2018 May;17(5):1061-1069. doi: 10.1158/1535-7163.MCT-17-0925. Epub 2018 Feb 13.

PMID:
29440295
6.

microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.

Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S.

Cancer Res. 2018 Apr 1;78(7):1833-1844. doi: 10.1158/0008-5472.CAN-17-2069. Epub 2018 Feb 1.

PMID:
29437039
7.

MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma.

Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R.

Mol Cancer Ther. 2017 Dec;16(12):2840-2848. doi: 10.1158/1535-7163.MCT-17-0400. Epub 2017 Aug 11.

PMID:
28802251
8.

A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.

Bucay N, Bhagirath D, Sekhon K, Yang T, Fukuhara S, Majid S, Shahryari V, Tabatabai Z, Greene KL, Hashimoto Y, Shiina M, Yamamura S, Tanaka Y, Deng G, Dahiya R, Saini S.

Cell Death Differ. 2017 Jul;24(7):1263-1274. doi: 10.1038/cdd.2017.69. Epub 2017 May 12.

9.

Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.

Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y.

Oncotarget. 2017 Jun 13;8(24):39087-39100. doi: 10.18632/oncotarget.16598. Erratum in: Oncotarget. 2018 Sep 25;9(75):34190.

10.

The role of miR-24 as a race related genetic factor in prostate cancer.

Hashimoto Y, Shiina M, Kato T, Yamamura S, Tanaka Y, Majid S, Saini S, Shahryari V, Kulkarni P, Dasgupta P, Mitsui Y, Sumida M, Deng G, Tabatabai L, Kumar D, Dahiya R.

Oncotarget. 2017 Mar 7;8(10):16581-16593. doi: 10.18632/oncotarget.15016.

11.

MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.

Colden M, Dar AA, Saini S, Dahiya PV, Shahryari V, Yamamura S, Tanaka Y, Stein G, Dahiya R, Majid S.

Cell Death Dis. 2017 Jan 26;8(1):e2572. doi: 10.1038/cddis.2017.15.

12.

MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.

Bucay N, Sekhon K, Yang T, Majid S, Shahryari V, Hsieh C, Mitsui Y, Deng G, Tabatabai ZL, Yamamura S, Calin GA, Dahiya R, Tanaka Y, Saini S.

Oncogene. 2017 May 11;36(19):2667-2679. doi: 10.1038/onc.2016.419. Epub 2016 Nov 28.

13.

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer.

Shahryari V, Nip H, Saini S, Dar AA, Yamamura S, Mitsui Y, Colden M, Bucay N, Tabatabai LZ, Greene K, Deng G, Tanaka Y, Dahiya R, Majid S.

J Vis Exp. 2016 Aug 29;(114). doi: 10.3791/54125.

14.

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer.

Bucay N, Sekhon K, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Greene K, Tanaka Y, Dahiya R, Deng G, Saini S.

Oncotarget. 2016 Oct 25;7(43):70388-70403. doi: 10.18632/oncotarget.11865.

15.

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.

Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, Hirata H, Yamamura S, Shahryari V, Deng G, Wong DK, Majid S, Shiina H, Dahiya R, Tanaka Y.

BMC Cancer. 2015 Dec 1;15:942. doi: 10.1186/s12885-015-1951-0.

16.

miRNA Expression Analyses in Prostate Cancer Clinical Tissues.

Bucay N, Shahryari V, Majid S, Yamamura S, Mitsui Y, Tabatabai ZL, Greene K, Deng G, Dahiya R, Tanaka Y, Saini S.

J Vis Exp. 2015 Sep 8;(103). doi: 10.3791/53123.

17.

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.

Chang I, Mitsui Y, Fukuhara S, Gill A, Wong DK, Yamamura S, Shahryari V, Tabatabai ZL, Dahiya R, Shin DM, Tanaka Y.

Oncotarget. 2015 Apr 10;6(10):7774-87.

18.

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.

Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H.

Oncotarget. 2015 Apr 20;6(11):9577-91.

19.

Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R.

Cancer Res. 2015 Apr 1;75(7):1322-31. doi: 10.1158/0008-5472.CAN-14-2931. Epub 2015 Jan 19.

20.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, Saini S, Yamamura S, Chiyomaru T, Hirata H, Ueno K, Arora S, Shahryari V, Deng G, Tabatabai ZL, Greene KL, Shin DM, Enokida H, Shiina H, Nonomura N, Dahiya R, Tanaka Y.

Tumour Biol. 2014 Oct;35(10):10223-30. doi: 10.1007/s13277-014-2292-3. Epub 2014 Jul 17.

PMID:
25027399
21.

Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Saini S, Majid S, Shahryari V, Tabatabai ZL, Arora S, Yamamura S, Tanaka Y, Dahiya R, Deng G.

Mol Cancer Ther. 2014 Jul;13(7):1952-63. doi: 10.1158/1535-7163.MCT-14-0017. Epub 2014 May 9.

22.

Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, Dahiya R, Yamamura S.

J Biol Chem. 2014 May 2;289(18):12550-65. doi: 10.1074/jbc.M113.488593. Epub 2014 Mar 10.

23.

Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.

Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Dahiya R.

Br J Cancer. 2014 Mar 18;110(6):1645-54. doi: 10.1038/bjc.2014.48. Epub 2014 Feb 6. Erratum in: Br J Cancer. 2018 Aug;119(3):388.

24.

MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.

Arora S, Saini S, Fukuhara S, Majid S, Shahryari V, Yamamura S, Chiyomaru T, Deng G, Tanaka Y, Dahiya R.

PLoS One. 2013 Nov 1;8(11):e78023. doi: 10.1371/journal.pone.0078023. eCollection 2013.

25.

Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.

Chang I, Majid S, Saini S, Zaman MS, Yamamura S, Chiyomaru T, Shahryari V, Fukuhara S, Deng G, Dahiya R, Tanaka Y.

Mol Cancer Ther. 2013 Jun;12(6):1049-59. doi: 10.1158/1535-7163.MCT-12-1187. Epub 2013 Apr 11.

26.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R.

PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.

27.

microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.

Ueno K, Hirata H, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R.

Br J Cancer. 2013 Apr 30;108(8):1659-67. doi: 10.1038/bjc.2013.125. Epub 2013 Mar 28.

28.

MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.

Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R.

PLoS One. 2013;8(1):e55502. doi: 10.1371/journal.pone.0055502. Epub 2013 Jan 30.

29.

Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R.

PLoS One. 2012;7(11):e51056. doi: 10.1371/journal.pone.0051056. Epub 2012 Nov 30.

30.

Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora S, Hirata H, Ueno K, Singh K, Tanaka Y, Dahiya R.

PLoS One. 2012;7(11):e50203. doi: 10.1371/journal.pone.0050203. Epub 2012 Nov 26.

31.

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Tanaka Y, Chiyomaru T, Deng G, Dahiya R.

Clin Cancer Res. 2013 Jan 1;19(1):73-84. doi: 10.1158/1078-0432.CCR-12-2952. Epub 2012 Nov 12.

32.

miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.

Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, Dahiya R.

Cancer Res. 2012 Dec 15;72(24):6435-46. doi: 10.1158/0008-5472.CAN-12-2181. Epub 2012 Oct 16.

33.

MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.

Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, Tanaka Y, Deng G, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(10):e46743. doi: 10.1371/journal.pone.0046743. Epub 2012 Oct 4.

34.

Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, Saini S, Hirata H, Ueno K, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Nakagawa M, Dahiya R.

PLoS One. 2012;7(8):e43812. doi: 10.1371/journal.pone.0043812. Epub 2012 Aug 23.

35.

miRNA-708 control of CD44(+) prostate cancer-initiating cells.

Saini S, Majid S, Shahryari V, Arora S, Yamamura S, Chang I, Zaman MS, Deng G, Tanaka Y, Dahiya R.

Cancer Res. 2012 Jul 15;72(14):3618-30. doi: 10.1158/0008-5472.CAN-12-0540. Epub 2012 May 2. Erratum in: Cancer Res. 2018 Jun 15;78(12):3404.

36.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.

37.

Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.

Chang I, Liu J, Majid S, Saini S, Zaman MS, Yamamura S, Shahryari V, Chiyomaru T, Deng G, Dahiya R, Tanaka Y.

Carcinogenesis. 2012 Feb;33(2):420-6. doi: 10.1093/carcin/bgr294. Epub 2011 Dec 9.

PMID:
22159223
38.

Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Hinoda Y, Dahiya R.

Mol Cancer Ther. 2012 Jan;11(1):244-53. doi: 10.1158/1535-7163.MCT-11-0592. Epub 2011 Nov 4.

39.

MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.

Hirata H, Hinoda Y, Ueno K, Shahryari V, Tabatabai ZL, Dahiya R.

Carcinogenesis. 2012 Jan;33(1):41-8. doi: 10.1093/carcin/bgr239. Epub 2011 Nov 1.

40.

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.

Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R.

Cancer Res. 2011 Oct 1;71(19):6208-19. doi: 10.1158/0008-5472.CAN-11-0073. Epub 2011 Aug 18.

41.

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, Yamamura S, Ueno K, Dahiya R.

Cancer Prev Res (Phila). 2011 Oct;4(10):1698-709. doi: 10.1158/1940-6207.CAPR-11-0267. Epub 2011 Aug 11.

42.

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.

Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, Tanaka Y, Dahiya R.

Carcinogenesis. 2011 May;32(5):772-8. doi: 10.1093/carcin/bgr036. Epub 2011 Feb 23.

43.

MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.

Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R.

Cancer Res. 2011 Apr 1;71(7):2611-21. doi: 10.1158/0008-5472.CAN-10-3666. Epub 2011 Feb 17.

44.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.

Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.

Clin Cancer Res. 2011 Aug 15;17(16):5287-98. doi: 10.1158/1078-0432.CCR-10-2619. Epub 2010 Dec 15.

45.

Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma.

Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y, Dahiya R.

Br J Cancer. 2011 Jan 18;104(2):308-15. doi: 10.1038/sj.bjc.6606028. Epub 2010 Nov 30.

46.

Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways.

Chen Y, Saini S, Zaman MS, Hirata H, Shahryari V, Deng G, Dahiya R.

Mol Carcinog. 2011 Jan;50(1):16-23. doi: 10.1002/mc.20680.

PMID:
20886547
47.

The functional significance of microRNA-145 in prostate cancer.

Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S, Majid S, Liu J, Khatri G, Tanaka Y, Dahiya R.

Br J Cancer. 2010 Jul 13;103(2):256-64. doi: 10.1038/sj.bjc.6605742. Epub 2010 Jun 29. Erratum in: Br J Cancer. 2011 Mar 1;104(5):892.

48.

Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.

Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, Tanaka Y, Dahiya R.

Cancer Res. 2010 Apr 1;70(7):2809-18. doi: 10.1158/0008-5472.CAN-09-4176. Epub 2010 Mar 23. Erratum in: Cancer Res. 2018 Jul 1;78(13):3740.

49.

Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.

Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R.

Cancer. 2010 Jan 1;116(1):66-76. doi: 10.1002/cncr.24662.

50.

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

Hirata H, Hinoda Y, Kikuno N, Suehiro Y, Shahryari V, Ahmad AE, Tabatabai ZL, Igawa M, Dahiya R.

J Urol. 2009 Apr;181(4):1907-12. doi: 10.1016/j.juro.2008.11.093. Epub 2009 Feb 23.

PMID:
19237173

Supplemental Content

Loading ...
Support Center